Randall Hendricks, MD
Orthopaedic Surgery · Tulsa, OKNPI 1932182870
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $17,108 of the $17,483 with a category attached, or 97.9%. Spinal Elements, Inc. accounts for 81.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $6,249 and has fallen 95.8% since, to $265 in 2025.
Across 21 payments — averaging $832.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spinal Elements, Inc.$14K
- Amendia, Inc.$3K
- Shoulder Innovations, Inc.$152
- Cerapedics Inc.$110
- Amgen$98
- Vertex$15
Across 11 payments — averaging $597.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Spinal Elements, Inc.$7K
What the payments were for
- Royalty or licence$17,10898%
- Food & beverage$3752%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spinal Elements, Inc. | 12 | $14,264 |
| Amendia, Inc. | 4 | $2,844 |
| Shoulder Innovations, Inc. | 1 | $152 |
| Cerapedics Inc. | 1 | $110 |
| Amgen | 2 | $98 |
| Vertex | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STCLINK$10,613
- Savannah T$3,895
- Medical Device$1,594
- Savannah-T CrossLink$1,006
- InSet System$152
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$110
How this compares
$17,483 in reported general payments places this provider in the 75th percentile of 263 orthopaedic surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 109 | $1,478 |
| Cyclobenzaprine Hcl | 80 | $987 |
| Methylprednisolone | 81 | $704 |
| Gabapentin | 55 | $354 |
| Tramadol Hcl | 34 | $231 |
| Meloxicam | 53 | $140 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $95 |
| Diazepam | 12 | $23 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Tulsa
- Yogesh MittalTulsa$6.6M
- Brian ChalkinTulsa$183K
- Kasra AhmadiniaTulsa$138K
- Sarat KunapuliTulsa$136K
- Keivan AbtahiTulsa$77K
- Rodney PlasterTulsa$61K
- Garrett WallerTulsa$52K
- Landon StallingsTulsa$46K
- Travis SmallTulsa$39K
- Blake ShockleyTulsa$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.